{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:21:28Z","timestamp":1794540088817,"version":"4.9.1"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001026","name":"National Breast Cancer Foundation","doi-asserted-by":"crossref","award":["PS-016-031"],"award-info":[{"award-number":["PS-016-031"]}],"id":[{"id":"10.13039\/501100001026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-3091-8","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T15:44:19Z","timestamp":1545320659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Mechanical suppression of osteolytic bone metastases in advanced breast cancer patients: a randomised controlled study protocol evaluating safety, feasibility and preliminary efficacy of exercise as a targeted medicine"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2794-0193","authenticated-orcid":false,"given":"Nicolas H.","family":"Hart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Galv\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christobel","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis R.","family":"Taaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kynan T.","family":"Feeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel A.","family":"Spry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daphne","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Clay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Redfern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert U.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,20]]},"reference":[{"issue":"2","key":"3091_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","volume":"10","author":"W Kozlow","year":"2005","unstructured":"Kozlow W, Guise TA. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia. 2005;10(2):169\u201380.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"1","key":"3091_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s13193-017-0706-6","volume":"9","author":"B Zacharia","year":"2018","unstructured":"Zacharia B, Subramaniam D, Joy J. Skeletal metastasis\u2014an epidemiological study. Ind J Surg Oncol. 2018;9(1):46\u201351.","journal-title":"Ind J Surg Oncol"},{"issue":"2","key":"3091_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/joim.12084","volume":"274","author":"AJ Redig","year":"2013","unstructured":"Redig AJ, McAllister SS. Breast cancer as a systemic disease: a view of metastasis. J Intern Med. 2013;274(2):113\u201326.","journal-title":"J Intern Med"},{"issue":"8","key":"3091_CR4","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrc1670","volume":"5","author":"B Weigelt","year":"2005","unstructured":"Weigelt B, Peterse JL, Van't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005;5(8):591\u2013602.","journal-title":"Nat Rev Cancer"},{"key":"3091_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.coche.2016.01.001","volume":"11","author":"LE Barney","year":"2016","unstructured":"Barney LE, Jansen LE, Polio SR, Galarza S, Lynch ME, Peyton SR. The predictive link between matrix and metastasis. Curr Opin Chem Eng. 2016;11:85\u201393.","journal-title":"Curr Opin Chem Eng"},{"issue":"1","key":"3091_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13046-015-0240-8","volume":"34","author":"N Wang","year":"2015","unstructured":"Wang N, Reeves KJ, Brown HK, Fowles AC, Docherty FE, Ottewell PD, et al. The frequency of osteolytic bone metastasis is determined by conditions of the soil, not the number of seeds; evidence from in vivo models of breast and prostate cancer. J Exp Clin Cancer Res. 2015;34(1):124.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3091_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4081\/oncol.2017.321","volume":"11","author":"F Macedo","year":"2017","unstructured":"Macedo F, Ladeira K, Pinho F, Saraiva N, Bonito N, Pinto L, et al. Bone metastases: an overview. Oncol Rev. 2017;11(1):321.","journal-title":"Oncol Rev"},{"key":"3091_CR8","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.addr.2014.08.009","volume":"79\u201380","author":"ME Lynch","year":"2014","unstructured":"Lynch ME, Fischbach C. Biomechanical forces in the skeleton and their relevance to bone metastasis: Biology and engineering considerations. Adv Drug Deliv Rev. 2014;79\u201380:119\u201334.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"3091_CR9","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00259-018-3959-6","volume":"45","author":"PF H\u00f8ilund-Carlsen","year":"2018","unstructured":"H\u00f8ilund-Carlsen PF, Hess S, Werner TJ, Alavi A. Cancer metastasizes to the bone marrow and not to the bone: time for a paradigm shift! Eur J Nucl Med Mol Imaging. 2018;45(6):893\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"3091_CR10","first-page":"1177","volume":"24","author":"K Hata","year":"2014","unstructured":"Hata K, Yoneda T. Bone metastases of breast cancer. Clin Calcium. 2014;24(8):1177\u201384.","journal-title":"Clin Calcium"},{"key":"3091_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fendo.2017.00112","volume":"8","author":"WP Cawthorn","year":"2017","unstructured":"Cawthorn WP, Scheller EL. Bone marrow adipose tissue: formation, function, and impact on health and disease. Front Endocrinol. 2017;8:112.","journal-title":"Front Endocrinol"},{"issue":"3","key":"3091_CR12","first-page":"114","volume":"17","author":"NH Hart","year":"2017","unstructured":"Hart NH, Nimphius S, Rantalainen T, Ireland A, Siafarikas A, Newton R. Mechanical basis of bone strength: influence of bone material, bone structure and muscle action. J Musculoskelet Nueronal Interact. 2017;17(3):114.","journal-title":"J Musculoskelet Nueronal Interact"},{"issue":"11","key":"3091_CR13","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1002\/jbmr.1966","volume":"28","author":"ME Lynch","year":"2013","unstructured":"Lynch ME, Brooks D, Mohanan S, Lee MJ, Polamraju P, Dent K, et al. In vivo tibial compression decreases osteolysis and tumor formation in a human metastatic breast cancer model. J Bone Miner Res. 2013;28(11):2357\u201367.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"3091_CR14","doi-asserted-by":"publisher","first-page":"e014458","DOI":"10.1136\/bmjopen-2016-014458","volume":"7","author":"NH Hart","year":"2017","unstructured":"Hart NH, Newton RU, Spry NA, Taaffe DR, Chambers SK, Feeney KT, et al. Can exercise suppress tumour growth in advanced prostate cancer patients with sclerotic bone metastases? A randomised, controlled study protocol examining feasibility, safety and efficacy. BMJ Open. 2017;7(5):e014458.","journal-title":"BMJ Open"},{"issue":"12","key":"3091_CR15","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1007\/s00198-013-2530-3","volume":"24","author":"R Rizzoli","year":"2013","unstructured":"Rizzoli R, Body J-J, Brandi M-L, Cannata-Andia J, Chappard D, El Maghraoui A, et al. Cancer-associated bone disease. Osteoporos Int. 2013;24(12):2929\u201353.","journal-title":"Osteoporos Int"},{"issue":"3","key":"3091_CR16","first-page":"834","volume":"97","author":"K Sanna-Maria","year":"2003","unstructured":"Sanna-Maria K, Mundy GR. Mechanisms of osteolytic bone metastases in breast carcinoma. Cancer. 2003;97(3):834\u20139.","journal-title":"Cancer"},{"issue":"4","key":"3091_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrendo.2010.227","volume":"7","author":"LJ Suva","year":"2011","unstructured":"Suva LJ, Washam C, Nicholas RW, Griffin RJ. Bone metastasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol. 2011;7(4):208\u201318.","journal-title":"Nat Rev Endocrinol"},{"issue":"20","key":"3091_CR18","doi-asserted-by":"publisher","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20):6243s\u20139s.","journal-title":"Clin Cancer Res"},{"issue":"16","key":"3091_CR19","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD. Mechanisms of bone metastasis. N Engl J Med. 2004;350(16):1655\u201364.","journal-title":"N Engl J Med"},{"issue":"3","key":"3091_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jbo.2016.05.004","volume":"5","author":"I Holen","year":"2016","unstructured":"Holen I. The bone microenvironment - multiple players involved in cancer progression. J Bone Oncol. 2016;5(3):87\u20139.","journal-title":"J Bone Oncol"},{"issue":"2","key":"3091_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4081\/oncol.2011.93","volume":"5","author":"SA Patel","year":"2011","unstructured":"Patel SA, Dave MA, Murthy RG, Helmy KY, Rameshwar P. Metastatic breast cancer cells in the bone marrow microenvironment: novel insights into oncoprotection. Oncol Rev. 2011;5(2):93\u2013102.","journal-title":"Oncol Rev"},{"issue":"2","key":"3091_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/cancers10020056","volume":"10","author":"I Roato","year":"2018","unstructured":"Roato I, Ferracini R. Cancer stem cells, bone and tumor microenvironment: key players in bone metastases. Cancers. 2018;10(2):56.","journal-title":"Cancers"},{"issue":"3","key":"3091_CR23","doi-asserted-by":"publisher","first-page":"e1002983","DOI":"10.1371\/journal.pcbi.1002983","volume":"9","author":"TW Secomb","year":"2013","unstructured":"Secomb TW, Alberding JP, Hsu R, Dewhirst MW, Pries AR. Angiogenesis: an adaptive dynamic biological patterning problem. PLoS Comput Biol. 2013;9(3):e1002983.","journal-title":"PLoS Comput Biol"},{"issue":"8","key":"3091_CR24","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1021\/cr500171e","volume":"115","author":"S Banerjee","year":"2015","unstructured":"Banerjee S, Pillai M, Knapp F. Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications. Chem Rev. 2015;115(8):2934\u201374.","journal-title":"Chem Rev"},{"issue":"1","key":"3091_CR25","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdw544","volume":"28","author":"F Cardoso","year":"2017","unstructured":"Cardoso F, Costa A, Senkus E, Aapro M, Andr\u00e9 F, Barrios C, et al. 3rd ESO\u2013ESMO international consensus guidelines for advanced breast cancer (ABC 3). Ann Oncol. 2017;28(1):16\u201333.","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"3091_CR26","first-page":"54","volume":"58","author":"S Cheal","year":"2017","unstructured":"Cheal S, Fung E, Xu H, Guo H-f, Patel M, Bell M, et al. Comparative efficacy and toxicity of 177Lu-vs 90Y-theranostic anti-HER2\/anti-DOTA (metal) pretargeted radioimmunotherapy (anti-HER2 DOTA-PRIT) of HER2-expressing breast cancer xenografts with curative intent. J Nuclear Med. 2017;58(Suppl 1):54.","journal-title":"J Nuclear Med"},{"issue":"10087","key":"3091_CR27","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/S0140-6736(16)32454-0","volume":"389","author":"C Denkert","year":"2017","unstructured":"Denkert C, Liedtke C, Tutt A, von Minckwitz G. Molecular alterations in triple-negative breast cancer\u2014the road to new treatment strategies. Lancet. 2017;389(10087):2430\u201342.","journal-title":"Lancet"},{"issue":"19","key":"3091_CR28","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1200\/JCO.2013.54.0948","volume":"32","author":"SH Giordano","year":"2014","unstructured":"Giordano SH, Temin S, Kirshner JJ, Chandarlapaty S, Crews JR, Davidson NE, et al. Systemic therapy for patients with advanced human epidermal growth factor receptor 2\u2013positive breast cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014;32(19):2078\u201399.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3091_CR29","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1177\/107327481201900209","volume":"19","author":"LS Loftus","year":"2012","unstructured":"Loftus LS, Edwards-Bennett S, Sokol GH. Systemic therapy for bone metastases. Cancer Control. 2012;19(2):145\u201353.","journal-title":"Cancer Control"},{"issue":"1","key":"3091_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.prro.2016.08.001","volume":"7","author":"S Lutz","year":"2017","unstructured":"Lutz S, Balboni T, Jones J, Lo S, Petit J, Rich SE, et al. Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline. Pract Radiat Oncol. 2017;7(1):4\u201312.","journal-title":"Pract Radiat Oncol"},{"issue":"25","key":"3091_CR31","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1200\/JCO.2017.73.7585","volume":"35","author":"GW Sledge Jr","year":"2017","unstructured":"Sledge GW Jr, Toi M, Neven P, Sohn J, Inoue K, Pivot X, et al. MONARCH 2: abemaciclib in combination with fulvestrant in women with HR+\/HER2\u2212 advanced breast cancer who had progressed while receiving endocrine therapy. J Clin Oncol. 2017;35(25):2875\u201384.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3091_CR32","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1200\/JCO.2010.32.5209","volume":"29","author":"CH Poznak Van","year":"2011","unstructured":"Van Poznak CH, Temin S, Yee GC, Janjan NA, Barlow WE, Biermann JS, et al. American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer. J Clin Oncol. 2011;29(9):1221\u20137.","journal-title":"J Clin Oncol"},{"key":"3091_CR33","first-page":"CD003474","volume":"10","author":"B O'Carrigan","year":"2017","unstructured":"O'Carrigan B, Wong MH, Willson ML, Stockler MR, Pavlakis N, Goodwin A. Bisphosphonates and other bone agents for breast cancer. Cochrane Database Syst Rev. 2017;10:CD003474.","journal-title":"Cochrane Database Syst Rev"},{"issue":"35","key":"3091_CR34","doi-asserted-by":"publisher","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","volume":"28","author":"AT Stopeck","year":"2010","unstructured":"Stopeck AT, Lipton A, Body J-J, Steger GG, Tonkin K, De Boer RH, et al. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol. 2010;28(35):5132\u20139.","journal-title":"J Clin Oncol"},{"key":"3091_CR35","volume-title":"Bisphosphonate drug holiday: who, when and how long","author":"DL Diab","year":"2013","unstructured":"Diab DL, Watts NB. Bisphosphonate drug holiday: who, when and how long. London: SAGE Publications Sage UK; 2013."},{"issue":"3","key":"3091_CR36","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00198-015-3453-y","volume":"27","author":"S Silverman","year":"2016","unstructured":"Silverman S, Adachi J, Dennison E. Bisphosphonate drug holidays: we reap what we sow. Osteoporos Int. 2016;27(3):849\u201352.","journal-title":"Osteoporos Int"},{"issue":"10","key":"3091_CR37","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1080\/17512433.2016.1203252","volume":"9","author":"L Vannucci","year":"2016","unstructured":"Vannucci L, Brandi ML. Pharmacological management of osteoporosis\u2013when to treat and when to stop. Expert Rev Clin Pharmacol. 2016;9(10):1315\u201322.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"2","key":"3091_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12018-013-9151-4","volume":"12","author":"A Ireland","year":"2014","unstructured":"Ireland A, Rittweger J, Degens H. The influence of muscular action on bone strength via exercise. Clin Rev Bone Mineral Metab. 2014;12(2):93\u2013102.","journal-title":"Clin Rev Bone Mineral Metab"},{"issue":"10","key":"3091_CR39","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s00198-009-1101-0","volume":"21","author":"R Nikander","year":"2010","unstructured":"Nikander R, Kannus P, Rantalainen T, Uusi-Rasi K, Heinonen A, Siev\u00e4nen H. Cross-sectional geometry of weight-bearing tibia in female athletes subjected to different exercise loadings. Osteoporos Int. 2010;21(10):1687\u201394.","journal-title":"Osteoporos Int"},{"issue":"4","key":"3091_CR40","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/bit.26524","volume":"115","author":"B Liu","year":"2018","unstructured":"Liu B, Han S, Hedrick BP, Modarres-Sadeghi Y, Lynch ME. Perfusion applied to a 3D model of bone metastasis results in uniformly dispersed mechanical stimuli. Biotechnol Bioeng. 2018;115(4):1076\u201385.","journal-title":"Biotechnol Bioeng"},{"issue":"15\u201316","key":"3091_CR41","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1089\/ten.tea.2016.0153","volume":"22","author":"ME Lynch","year":"2016","unstructured":"Lynch ME, Chiou AE, Lee MJ, Marcott SC, Polamraju PV, Lee Y, et al. Three-dimensional mechanical loading modulates the osteogenic response of mesenchymal stem cells to tumor-derived soluble signals. Tissue Eng A. 2016;22(15\u201316):1006\u201315.","journal-title":"Tissue Eng A"},{"issue":"1","key":"3091_CR42","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/nyas.13411","volume":"1402","author":"CP Cardozo","year":"2017","unstructured":"Cardozo CP, Graham ZA. Muscle\u2013bone interactions: movement in the field of mechano\u2013humoral coupling of muscle and bone. Ann N Y Acad Sci. 2017;1402(1):10\u20137.","journal-title":"Ann N Y Acad Sci"},{"key":"3091_CR43","doi-asserted-by":"publisher","unstructured":"Karsenty G, Mera P. Molecular bases of the crosstalk between bone and muscle. Bone. 2017. https:\/\/doi.org\/10.1016\/j.bone.2017.04.006 .","DOI":"10.1016\/j.bone.2017.04.006"},{"issue":"1","key":"3091_CR44","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11914-017-0344-5","volume":"15","author":"JN Regan","year":"2017","unstructured":"Regan JN, Trivedi T, Guise TA, Waning DL. The role of TGF\u03b2 in bone-muscle crosstalk. Curr Osteoporosis Rep. 2017;15(1):18\u201323.","journal-title":"Curr Osteoporosis Rep"},{"issue":"11","key":"3091_CR45","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nm.3961","volume":"21","author":"DL Waning","year":"2015","unstructured":"Waning DL, Mohammad KS, Reiken S, Xie W, Andersson DC, John S, et al. Excess TGF-\u03b2 mediates muscle weakness associated with bone metastases in mice. Nat Med. 2015;21(11):1262\u201371.","journal-title":"Nat Med"},{"issue":"11","key":"3091_CR46","doi-asserted-by":"publisher","first-page":"a029793","DOI":"10.1101\/cshperspect.a029793","volume":"7","author":"C Hoffmann","year":"2017","unstructured":"Hoffmann C, Weigert C. Skeletal muscle as an endocrine organ: the role of myokines in exercise adaptations. Cold Spring Harbor Perspect Med. 2017;7(11):a029793.","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"1","key":"3091_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cmet.2017.09.015","volume":"27","author":"P Hojman","year":"2018","unstructured":"Hojman P, Gehl J, Christensen JF, Pedersen BK. Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab. 2018;27(1):10\u201321.","journal-title":"Cell Metab"},{"issue":"3","key":"3091_CR48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/SPC.0000000000000276","volume":"11","author":"NH Hart","year":"2017","unstructured":"Hart NH, Galv\u00e3o DA, Newton RU. Exercise medicine for advanced prostate cancer. Curr Opin Support Palliat Care. 2017;11(3):247\u201357.","journal-title":"Curr Opin Support Palliat Care"},{"issue":"6","key":"3091_CR49","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.trecan.2017.04.007","volume":"3","author":"A Ruiz-Casado","year":"2017","unstructured":"Ruiz-Casado A, Mart\u00edn-Ruiz A, P\u00e9rez LM, Provencio M, Fiuza-Luces C, Lucia A. Exercise and the hallmarks of cancer. Trends Cancer. 2017;3(6):423\u201341.","journal-title":"Trends Cancer"},{"issue":"5","key":"3091_CR50","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nrurol.2016.46","volume":"13","author":"DA Galv\u00e3o","year":"2016","unstructured":"Galv\u00e3o DA, Taaffe DR, Spry N, Gardiner RA, Taylor R, Risbridger GP, et al. Enhancing active surveillance of prostate cancer: the potential of exercise medicine. Nat Rev Urol. 2016;13(5):258.","journal-title":"Nat Rev Urol"},{"issue":"5","key":"3091_CR51","doi-asserted-by":"publisher","first-page":"e022899","DOI":"10.1136\/bmjopen-2018-022899","volume":"8","author":"RU Newton","year":"2018","unstructured":"Newton RU, Kenfield SA, Hart NH, Chan JM, Courneya KS, Catto J, et al. Intense exercise for survival among men with metastatic castrate-resistant prostate cancer (INTERVAL-GAP4): a multicentre, randomised, controlled phase III study protocol. BMJ Open. 2018;8(5):e022899.","journal-title":"BMJ Open"},{"issue":"2","key":"3091_CR52","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1200\/JCO.2009.23.2488","volume":"28","author":"DA Galvao","year":"2010","unstructured":"Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010;28(2):340\u20137.","journal-title":"J Clin Oncol"},{"key":"3091_CR53","doi-asserted-by":"publisher","unstructured":"Sheill G, Guinan EM, Peat N, Hussey J. Considerations for exercise prescription in patients with bone metastases: a comprehensive narrative review. PM R. 2018. https:\/\/doi.org\/10.1016\/j.pmrj.2018.02.006 .","DOI":"10.1016\/j.pmrj.2018.02.006"},{"issue":"6","key":"3091_CR54","doi-asserted-by":"publisher","first-page":"e12575","DOI":"10.1111\/ecc.12575","volume":"26","author":"E Zopf","year":"2017","unstructured":"Zopf E, Newton RU, Taaffe DR, Spry N, Cormie P, Joseph D, et al. Associations between aerobic exercise levels and physical and mental health outcomes in men with bone metastatic prostate cancer: a cross-sectional investigation. Eur J Cancer Care. 2017;26(6):e12575.","journal-title":"Eur J Cancer Care"},{"issue":"4","key":"3091_CR55","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/pcan.2013.22","volume":"16","author":"P Cormie","year":"2013","unstructured":"Cormie P, Newton RU, Spry N, Joseph D, Taaffe DR, Galvao DA. Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases. Prostate Cancer Prostatic Dis. 2013;16(4):328\u201335.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"3091_CR56","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1186\/1471-2407-11-517","volume":"11","author":"DA Galv\u00e3o","year":"2011","unstructured":"Galv\u00e3o DA, Taaffe DR, Cormie P, Spry N, Chambers SK, Peddle-McIntyre C, et al. Efficacy and safety of a modular multi-modal exercise program in prostate cancer patients with bone metastases: a randomized controlled trial. BMC Cancer. 2011;11(1):517.","journal-title":"BMC Cancer"},{"issue":"3","key":"3091_CR57","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1249\/MSS.0000000000001454","volume":"50","author":"DA Galvao","year":"2018","unstructured":"Galvao DA, Taaffe DR, Spry N, Cormie P, Joseph D, Chambers SK, et al. Exercise preserves physical function in prostate cancer patients with bone metastases. Med Sci Sports Exerc. 2018;50(3):393.","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"3091_CR58","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s00520-013-2103-1","volume":"22","author":"P Cormie","year":"2014","unstructured":"Cormie P, Galv\u00e3o DA, Spry N, Joseph D, Taaffe DR, Newton RU. Functional benefits are sustained after a program of supervised resistance exercise in cancer patients with bone metastases: longitudinal results of a pilot study. Support Care Cancer. 2014;22(6):1537\u201348.","journal-title":"Support Care Cancer"},{"issue":"1","key":"3091_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1471-2407-14-67","volume":"14","author":"H Rief","year":"2014","unstructured":"Rief H, Omlor G, Akbar M, Welzel T, Bruckner T, Rieken S, et al. Feasibility of isometric spinal muscle training in patients with bone metastases under radiation therapy-first results of a randomized pilot trial. BMC Cancer. 2014;14(1):67.","journal-title":"BMC Cancer"},{"issue":"1","key":"3091_CR60","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.radonc.2014.06.008","volume":"112","author":"H Rief","year":"2014","unstructured":"Rief H, Petersen LC, Omlor G, Akbar M, Bruckner T, Rieken S, et al. The effect of resistance training during radiotherapy on spinal bone metastases in cancer patients\u2013a randomized trial. Radiother Oncol. 2014;112(1):133\u20139.","journal-title":"Radiother Oncol"},{"issue":"3","key":"3091_CR61","first-page":"155","volume":"17","author":"A Ireland","year":"2017","unstructured":"Ireland A, Rittweger J. Exercise for osteoporosis: how to navigate between overeagerness and defeatism. J Musculoskelet Neuronal Interact. 2017;17(3):155\u201361.","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"2","key":"3091_CR62","first-page":"114","volume":"6","author":"IW Mak","year":"2014","unstructured":"Mak IW, Evaniew N, Ghert M. Lost in translation: animal models and clinical trials in cancer treatment. Am J Transl Res. 2014;6(2):114\u20138.","journal-title":"Am J Transl Res"},{"issue":"3","key":"3091_CR63","doi-asserted-by":"publisher","first-page":"e1000245","DOI":"10.1371\/journal.pmed.1000245","volume":"7","author":"HB Worp Van der","year":"2010","unstructured":"Van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O'Collins V, et al. Can animal models of disease reliably inform human studies? PLoS Med. 2010;7(3):e1000245.","journal-title":"PLoS Med"},{"issue":"2","key":"3091_CR64","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/bju.12646","volume":"115","author":"P Cormie","year":"2015","unstructured":"Cormie P, Galv\u00e3o DA, Spry N, Joseph D, Chee R, Taaffe DR, et al. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial. BJU Int. 2015;115(2):256\u201366.","journal-title":"BJU Int"},{"issue":"4","key":"3091_CR65","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/sj.pcan.4500975","volume":"10","author":"D Galvao","year":"2007","unstructured":"Galvao D, Taaffe D, Spry N, Newton R. Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer. Prostate Cancer Prostatic Dis. 2007;10(4):340.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"3091_CR66","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.eururo.2013.09.041","volume":"65","author":"DA Galvao","year":"2014","unstructured":"Galvao DA, Spry N, Denham J, Taaffe DR, Cormie P, Joseph D, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol. 2014;65(5):856\u201364.","journal-title":"Eur Urol"},{"issue":"1","key":"3091_CR67","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/1471-2407-9-419","volume":"9","author":"DA Galv\u00e3o","year":"2009","unstructured":"Galv\u00e3o DA, Spry N, Taaffe DR, Denham J, Joseph D, Lamb DS, et al. A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial. BMC Cancer. 2009;9(1):419.","journal-title":"BMC Cancer"},{"issue":"1","key":"3091_CR68","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/1471-2407-12-432","volume":"12","author":"RU Newton","year":"2012","unstructured":"Newton RU, Taaffe DR, Spry N, Cormie P, Chambers SK, Gardiner RA, et al. Can exercise ameliorate treatment toxicity during the initial phase of testosterone deprivation in prostate cancer patients? Is this more effective than delayed rehabilitation? BMC Cancer. 2012;12(1):432.","journal-title":"BMC Cancer"},{"issue":"20","key":"3091_CR69","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke H, Yerushalmi R, Woods R, Cheang MCU, Voduc D, Speers CH, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28(20):3271\u20137.","journal-title":"J Clin Oncol"},{"issue":"5","key":"3091_CR70","doi-asserted-by":"publisher","first-page":"djv040","DOI":"10.1093\/jnci\/djv040","volume":"107","author":"AS Betof","year":"2015","unstructured":"Betof AS, Lascola CD, Weitzel D, Landon C, Scarbrough PM, Devi GR, et al. Modulation of murine breast tumor vascularity, hypoxia, and chemotherapeutic response by exercise. JNCI. 2015;107(5):djv040.","journal-title":"JNCI"},{"issue":"2","key":"3091_CR71","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1152\/japplphysiol.01575.2011","volume":"113","author":"LW Jones","year":"2012","unstructured":"Jones LW, Antonelli J, Masko EM, Broadwater G, Lascola CD, Fels D, et al. Exercise modulation of the host-tumor interaction in an orthotopic model of murine prostate cancer. J Appl Physiol. 2012;113(2):263\u201372.","journal-title":"J Appl Physiol"},{"issue":"5","key":"3091_CR72","doi-asserted-by":"publisher","first-page":"e97033","DOI":"10.1371\/journal.pone.0097033","volume":"9","author":"G Wolff","year":"2014","unstructured":"Wolff G, Balke JE, Andras IE, Park M, Toborek M. Exercise modulates redox-sensitive small GTPase activity in the brain microvasculature in a model of brain metastasis formation. PLoS One. 2014;9(5):e97033.","journal-title":"PLoS One"},{"issue":"9","key":"3091_CR73","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1158\/1940-6207.CAPR-12-0416","volume":"6","author":"LW Jones","year":"2013","unstructured":"Jones LW, Fels DR, West M, Allen JD, Broadwater G, Barry WT, et al. Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy. Cancer Prev Res. 2013;6(9):925\u201337.","journal-title":"Cancer Prev Res"},{"issue":"5","key":"3091_CR74","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/bjc.2014.662","volume":"112","author":"OK Glass","year":"2015","unstructured":"Glass OK, Inman BA, Broadwater G, Courneya KS, Mackey JR, Goruk S, et al. Effect of aerobic training on the host systemic milieu in patients with solid tumours: an exploratory correlative study. Br J Cancer. 2015;112(5):825.","journal-title":"Br J Cancer"},{"issue":"Supplement 1","key":"3091_CR75","doi-asserted-by":"publisher","first-page":"27S","DOI":"10.2967\/jnumed.115.157867","volume":"57","author":"GJ Cook","year":"2016","unstructured":"Cook GJ, Azad GK, Goh V. Imaging bone metastases in breast cancer: staging and response assessment. J Nuclear Med. 2016;57(Supplement 1):27S\u201333S.","journal-title":"J Nuclear Med"},{"issue":"6","key":"3091_CR76","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S1470-2045(09)70088-9","volume":"10","author":"CM Costelloe","year":"2009","unstructured":"Costelloe CM, Rohren EM, Madewell JE, Hamaoka T, Theriault RL, Yu T-K, et al. Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol. 2009;10(6):606\u201314.","journal-title":"Lancet Oncol"},{"issue":"15","key":"3091_CR77","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/j.ejca.2014.07.002","volume":"50","author":"F Lecouvet","year":"2014","unstructured":"Lecouvet F, Talbot JN, Messiou C, Bourguet P, Liu Y, de Souza NM. Monitoring the response of bone metastases to treatment with magnetic resonance imaging and nuclear medicine techniques: a review and position statement by the European Organisation for Research and Treatment of Cancer imaging group. Eur J Cancer. 2014;50(15):2519\u201331.","journal-title":"Eur J Cancer"},{"key":"3091_CR78","first-page":"769753","volume":"2011","author":"LM Shah","year":"2011","unstructured":"Shah LM, Salzman KL. Imaging of spinal metastatic disease. Int J Surg Oncol. 2011;2011:769753.","journal-title":"Int J Surg Oncol"},{"issue":"3","key":"3091_CR79","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","volume":"31","author":"PA Yushkevich","year":"2006","unstructured":"Yushkevich PA, Piven J, Hazlett HC, Smith RG, Ho S, Gee JC, et al. User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. NeuroImage. 2006;31(3):1116\u201328.","journal-title":"NeuroImage"},{"issue":"9","key":"3091_CR80","doi-asserted-by":"publisher","first-page":"e6896","DOI":"10.1371\/journal.pone.0006896","volume":"4","author":"LK Dunn","year":"2009","unstructured":"Dunn LK, Mohammad KS, Fournier PGJ, McKenna CR, Davis HW, Niewolna M, et al. Hypoxia and TGF-\u03b2 drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment. PLoS One. 2009;4(9):e6896.","journal-title":"PLoS One"},{"key":"3091_CR81","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1097\/01.blo.0000093055.96273.69","volume":"415","author":"TA Guise","year":"2003","unstructured":"Guise TA, Chirgwin JM. Transforming growth factor-beta in osteolytic breast cancer bone metastases. Clin Orthop Relat Res\u00ae. 2003;415:S32\u2013S8.","journal-title":"Clin Orthop Relat Res\u00ae"},{"issue":"9","key":"3091_CR82","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1158\/0008-5472.CAN-06-2355","volume":"67","author":"T Hiraga","year":"2007","unstructured":"Hiraga T, Kizaka-Kondoh S, Hirota K, Hiraoka M, Yoneda T. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer. Cancer Res. 2007;67(9):4157\u201363.","journal-title":"Cancer Res"},{"issue":"3","key":"3091_CR83","first-page":"382","volume":"1863","author":"GL Semenza","year":"2016","unstructured":"Semenza GL. The hypoxic tumor microenvironment: a driving force for breast cancer progression. Biochimica et Biophysica Acta (BBA)-Molecular. Cell Res. 2016;1863(3):382\u201391.","journal-title":"Cell Res"},{"issue":"3\u20134","key":"3091_CR84","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10555-012-9375-7","volume":"31","author":"Y Drabsch","year":"2012","unstructured":"Drabsch Y, Ten Dijke P. TGF-\u03b2 signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev. 2012;31(3\u20134):553\u201368.","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"3091_CR85","first-page":"620","volume":"14","author":"NH Hart","year":"2015","unstructured":"Hart NH, Nimphius S, Spiteri T, Cochrane JL, Newton RU. Segmental musculoskeletal examinations using dual-energy x-ray absorptiometry (DXA): positioning and analysis considerations. J Sports Sci Med. 2015;14(3):620.","journal-title":"J Sports Sci Med"},{"key":"3091_CR86","volume-title":"QDR for Windows XP Reference Manual","author":"Anon","year":"2014","unstructured":"Anon. QDR for Windows XP Reference Manual. Bedford: Hologic Inc.; 2014."},{"issue":"7","key":"3091_CR87","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1249\/MSS.0000000000000897","volume":"48","author":"NH Hart","year":"2016","unstructured":"Hart NH, Nimphius S, Weber J, Spiteri T, Rantalainen T, Dobbin M, et al. Musculoskeletal asymmetry in football athletes: a product of limb function over time. Med Sci Sports Exerc. 2016;48(7):1379\u201387.","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"3091_CR88","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jocd.2017.07.002","volume":"21","author":"T Rantalainen","year":"2018","unstructured":"Rantalainen T, Chivers P, Beck BR, Robertson S, Hart NH, Nimphius S, et al. Please don't move\u2014evaluating motion artifact from peripheral quantitative computed tomography scans using textural features. J Clin Densitom. 2018;21(2):260\u20138.","journal-title":"J Clin Densitom"},{"issue":"1","key":"3091_CR89","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00003677-200101000-00006","volume":"29","author":"SM McGill","year":"2001","unstructured":"McGill SM. Low back stability: from formal description to issues for performance and rehabilitation. Exerc Sport Sci Rev. 2001;29(1):26\u201331.","journal-title":"Exerc Sport Sci Rev"},{"key":"3091_CR90","volume-title":"A scale of magnitudes for effect statistics. A new view of statistics","author":"WG Hopkins","year":"2002","unstructured":"Hopkins WG. A scale of magnitudes for effect statistics. A new view of statistics. 2002. Available from: www.sportsci.org\/resource\/stats\/effectmag.html ."},{"issue":"3","key":"3091_CR91","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/2229-3485.83221","volume":"2","author":"SK Gupta","year":"2011","unstructured":"Gupta SK. Intention-to-treat concept: a review. Perspect Clin Res. 2011;2(3):109.","journal-title":"Perspect Clin Res"},{"issue":"1","key":"3091_CR92","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-2288-13-92","volume":"13","author":"L Thabane","year":"2013","unstructured":"Thabane L, Mbuagbaw L, Zhang S, Samaan Z, Marcucci M, Ye C, et al. A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol. 2013;13(1):92.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"3091_CR93","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1471-2288-14-118","volume":"14","author":"ML Bell","year":"2014","unstructured":"Bell ML, Fiero M, Horton NJ, Hsu C-H. Handling missing data in RCTs; a review of the top medical journals. BMC Med Res Methodol. 2014;14(1):118.","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"3091_CR94","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/1754-9485.12115","volume":"58","author":"N Beydoun","year":"2014","unstructured":"Beydoun N, Bucci JA, Chin YS, Spry N, Newton R, Galv\u00e3o DA. Prospective study of exercise intervention in prostate cancer patients on androgen deprivation therapy. J Med Imaging Radiat Oncol. 2014;58(3):369\u201376.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"6","key":"3091_CR95","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/ncpuro1104","volume":"5","author":"DA Galv\u00e3o","year":"2008","unstructured":"Galv\u00e3o DA, Newton RU, Taaffe DR, Spry N. Can exercise ameliorate the increased risk of cardiovascular disease and diabetes associated with ADT? Nat Rev Urol. 2008;5(6):306.","journal-title":"Nat Rev Urol"},{"issue":"2","key":"3091_CR96","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3109\/0284186X.2012.742564","volume":"52","author":"LW Jones","year":"2013","unstructured":"Jones LW, Alfano CM. Exercise-oncology research: past, present, and future. Acta Oncol. 2013;52(2):195\u2013215.","journal-title":"Acta Oncol"},{"issue":"23","key":"3091_CR97","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1200\/JCO.2015.65.6603","volume":"34","author":"LW Jones","year":"2016","unstructured":"Jones LW, Habel LA, Weltzien E, Castillo A, Gupta D, Kroenke CH, et al. Exercise and risk of cardiovascular events in women with nonmetastatic breast cancer. J Clin Oncol. 2016;34(23):2743.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3091_CR98","doi-asserted-by":"publisher","first-page":"55","DOI":"10.15280\/jlm.2017.7.2.55","volume":"7","author":"TH Kim","year":"2017","unstructured":"Kim TH, Chang JS, Kong ID. Effects of exercise training on physical fitness and biomarker levels in breast cancer survivors. J Lifestyle Med. 2017;7(2):55\u201362.","journal-title":"J Lifestyle Med"},{"issue":"2","key":"3091_CR99","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/oby.21729","volume":"25","author":"GA Thomas","year":"2017","unstructured":"Thomas GA, Cartmel B, Harrigan M, Fiellin M, Capozza S, Zhou Y, et al. The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors. Obesity. 2017;25(2):346\u201351.","journal-title":"Obesity"},{"issue":"917606","key":"3091_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/917606","volume":"2015","author":"AA Kirkham","year":"2015","unstructured":"Kirkham AA, Davis MK. Exercise prevention of cardiovascular disease in breast cancer survivors. J Oncol. 2015;2015(917606):1\u201313.","journal-title":"J Oncol"},{"issue":"5","key":"3091_CR101","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1161\/CIRCULATIONAHA.111.021774","volume":"124","author":"JM Scott","year":"2011","unstructured":"Scott JM, Khakoo A, Mackey JR, Haykowsky MJ, Douglas PS, Jones LW. Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms. Circulation. 2011;124(5):642\u201350.","journal-title":"Circulation"},{"issue":"18","key":"3091_CR102","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1200\/JCO.2005.03.6749","volume":"24","author":"RL Ahmed","year":"2006","unstructured":"Ahmed RL, Thomas W, Yee D, Schmitz KH. Randomized controlled trial of weight training and lymphedema in breast cancer survivors. J Clin Oncol. 2006;24(18):2765\u201372.","journal-title":"J Clin Oncol"},{"issue":"24","key":"3091_CR103","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1001\/jama.2010.1837","volume":"304","author":"KH Schmitz","year":"2010","unstructured":"Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, et al. Weight lifting for women at risk for breast cancer\u2013related lymphedema: a randomized trial. JAMA. 2010;304(24):2699\u2013705.","journal-title":"JAMA"},{"issue":"14","key":"3091_CR104","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1158\/0008-5472.CAN-16-0887","volume":"76","author":"KA Ashcraft","year":"2016","unstructured":"Ashcraft KA, Peace RM, Betof AS, Dewhirst MW, Jones LW. Efficacy and mechanisms of aerobic exercise on cancer initiation, progression, and metastasis: a critical systematic review of in vivo preclinical data. Cancer Res. 2016;76(14):4032\u201350.","journal-title":"Cancer Res"},{"issue":"Suppl","key":"3091_CR105","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1016\/j.bbi.2012.05.001","volume":"30","author":"AS Betof","year":"2013","unstructured":"Betof AS, Dewhirst MW, Jones LW. Effects and potential mechanisms of exercise training on cancer progression: a translational perspective. Brain Behav Immun. 2013;30(Suppl):S75\u201387.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"3091_CR106","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10549-017-4129-4","volume":"162","author":"C Dethlefsen","year":"2017","unstructured":"Dethlefsen C, Pedersen KS, Hojman P. Every exercise bout matters: linking systemic exercise responses to breast cancer control. Breast Cancer Res Treat. 2017;162(3):399\u2013408.","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"3091_CR107","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/ecc.12068","volume":"22","author":"M Ergun","year":"2013","unstructured":"Ergun M, Eyigor S, Karaca B, Kisim A, Uslu R. Effects of exercise on angiogenesis and apoptosis-related molecules, quality of life, fatigue and depression in breast cancer patients. Eur J Cancer Care. 2013;22(5):626\u201337.","journal-title":"Eur J Cancer Care"},{"issue":"2","key":"3091_CR108","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/sj.pcan.4500991","volume":"11","author":"DA Galv\u00e3o","year":"2008","unstructured":"Galv\u00e3o DA, Nosaka K, Taaffe D, Peake J, Spry N, Suzuki K, et al. Endocrine and immune responses to resistance training in prostate cancer patients. Prostate Cancer Prostatic Dis. 2008;11(2):160.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"9","key":"3091_CR109","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1158\/1055-9965.EPI-16-0223","volume":"25","author":"BD Hayes","year":"2016","unstructured":"Hayes BD, Brady L, Pollak M, Finn SP. Exercise and prostate cancer: evidence and proposed mechanisms for disease modification. Cancer Epidemiol Prev Biomark. 2016;25(9):1281\u20138.","journal-title":"Cancer Epidemiol Prev Biomark"},{"key":"3091_CR110","volume-title":"Exercise training, tumour metabolism, tumour-host interaction and lactate shuttle theory. 4th Annual Meeting of the International Society of Proton Dynamics in Cancer","year":"2013","unstructured":"Hoffman P, editor. Exercise training, tumour metabolism, tumour-host interaction and lactate shuttle theory. 4th Annual Meeting of the International Society of Proton Dynamics in Cancer. Garching: Frontiers in Pharmacology; 2013."},{"issue":"7","key":"3091_CR111","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.molmed.2016.05.007","volume":"22","author":"M Idorn","year":"2016","unstructured":"Idorn M, Hojman P. Exercise-dependent regulation of NK cells in cancer protection. Trends Mol Med. 2016;22(7):565\u201377.","journal-title":"Trends Mol Med"},{"issue":"4","key":"3091_CR112","doi-asserted-by":"publisher","first-page":"dju042","DOI":"10.1093\/jnci\/dju042","volume":"106","author":"LW Jones","year":"2014","unstructured":"Jones LW, Dewhirst MW. Therapeutic properties of aerobic training after a cancer diagnosis: more than a one-trick pony? JNCI. 2014;106(4):dju042.","journal-title":"JNCI"},{"issue":"10","key":"3091_CR113","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nrc.2017.78","volume":"17","author":"GJ Koelwyn","year":"2017","unstructured":"Koelwyn GJ, Quail DF, Zhang X, White RM, Jones LW. Exercise-dependent regulation of the tumour microenvironment. Nat Rev Cancer. 2017;17(10):620\u201332.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"3091_CR114","first-page":"908","volume":"29","author":"GJ Koelwyn","year":"2015","unstructured":"Koelwyn GJ, Wennerberg E, Demaria S, Jones LW. Exercise in regulation of inflammation-immune axis function in cancer initiation and progression. Oncology (Williston Park). 2015;29(12):908\u201320.","journal-title":"Oncology (Williston Park)"},{"issue":"2","key":"3091_CR115","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/PPO.0000000000000096","volume":"21","author":"L Pedersen","year":"2015","unstructured":"Pedersen L, Christensen JF, Hojman P. Effects of exercise on tumor physiology and metabolism. Cancer J. 2015;21(2):111\u20136.","journal-title":"Cancer J"},{"key":"3091_CR116","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.maturitas.2017.04.022","volume":"105","author":"S Pudkasam","year":"2017","unstructured":"Pudkasam S, Tangalakis K, Chinlumprasert N, Apostolopoulos V, Stojanovska L. Breast cancer and exercise: the role of adiposity and immune markers. Maturitas. 2017;105:16\u201322.","journal-title":"Maturitas"},{"issue":"40","key":"3091_CR117","doi-asserted-by":"publisher","first-page":"65429","DOI":"10.18632\/oncotarget.11748","volume":"7","author":"KL Schadler","year":"2016","unstructured":"Schadler KL, Thomas NJ, Galie PA, Bhang DH, Roby KC, Addai P, et al. Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy. Oncotarget. 2016;7(40):65429\u201340.","journal-title":"Oncotarget"},{"issue":"8","key":"3091_CR118","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1136\/bjsports-2016-096343","volume":"51","author":"RJ Thomas","year":"2016","unstructured":"Thomas RJ, Kenfield SA, Jimenez A. Exercise-induced biochemical changes and their potential influence on cancer: a scientific review. Br J Sports Med. 2016;51(8):640\u20134.","journal-title":"Br J Sports Med"},{"key":"3091_CR119","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejca.2016.07.010","volume":"66","author":"G Ammitzb\u00f8ll","year":"2016","unstructured":"Ammitzb\u00f8ll G, S\u00f8gaard K, Karlsen RV, Tj\u00f8nneland A, Johansen C, Frederiksen K, et al. Physical activity and survival in breast cancer. Eur J Cancer. 2016;66:67\u201374.","journal-title":"Eur J Cancer"},{"issue":"1","key":"3091_CR120","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1158\/1055-9965.EPI-14-0707","volume":"24","author":"SE Bonn","year":"2015","unstructured":"Bonn SE, Sj\u00f6lander A, Lagerros YT, Wiklund F, Stattin P, Holmberg E, et al. Physical activity and survival among men diagnosed with prostate cancer. Cancer Epidemiol Prev Biomark. 2015;24(1):57\u201364.","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"7","key":"3091_CR121","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1200\/JCO.2012.45.9735","volume":"31","author":"PT Campbell","year":"2013","unstructured":"Campbell PT, Patel AV, Newton CC, Jacobs EJ, Gapstur SM. Associations of recreational physical activity and leisure time spent sitting with colorectal cancer survival. J Clin Oncol. 2013;31(7):876\u201385.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3091_CR122","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1158\/1940-6207.CAPR-10-0355","volume":"4","author":"X Chen","year":"2011","unstructured":"Chen X, Lu W, Zheng W, Gu K, Matthews CE, Chen Z, et al. Exercise after diagnosis of breast cancer in association with survival. Cancer Prev Res. 2011;4(9):1409\u201318.","journal-title":"Cancer Prev Res"},{"issue":"4","key":"3091_CR123","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.eururo.2015.12.032","volume":"70","author":"CM Friedenreich","year":"2016","unstructured":"Friedenreich CM, Wang Q, Neilson HK, Kopciuk KA, McGregor SE, Courneya KS. Physical activity and survival after prostate cancer. Eur Urol. 2016;70(4):576\u201385.","journal-title":"Eur Urol"},{"key":"3091_CR124","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fpubh.2017.00019","volume":"5","author":"AS Gunnell","year":"2017","unstructured":"Gunnell AS, Joyce S, Tomlin S, Taaffe DR, Cormie P, Newton RU, et al. Physical activity and survival among long-term cancer survivor and non-cancer cohorts. Front Public Health. 2017;5:19.","journal-title":"Front Public Health"},{"issue":"1","key":"3091_CR125","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/gut.2005.068189","volume":"55","author":"AM Haydon","year":"2006","unstructured":"Haydon AM, MacInnis RJ, English DR, Giles GG. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut. 2006;55(1):62\u20137.","journal-title":"Gut"},{"issue":"2","key":"3091_CR126","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1158\/1055-9965.EPI-07-0771","volume":"17","author":"CN Holick","year":"2008","unstructured":"Holick CN, Newcomb PA, Trentham-Dietz A, Titus-Ernstoff L, Bersch AJ, Stampfer MJ, et al. Physical activity and survival after diagnosis of invasive breast Cancer. Cancer Epidemiol Prev Biomark. 2008;17(2):379\u201386.","journal-title":"Cancer Epidemiol Prev Biomark"},{"issue":"20","key":"3091_CR127","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1001\/jama.293.20.2479","volume":"293","author":"MD Holmes","year":"2005","unstructured":"Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293(20):2479\u201386.","journal-title":"JAMA"},{"issue":"3","key":"3091_CR128","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s12032-010-9536-x","volume":"28","author":"EM Ibrahim","year":"2011","unstructured":"Ibrahim EM, Al-Homaidh A. Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies. Med Oncol. 2011;28(3):753\u201365.","journal-title":"Med Oncol"},{"issue":"6","key":"3091_CR129","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1200\/JCO.2010.31.5226","volume":"29","author":"SA Kenfield","year":"2011","unstructured":"Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol. 2011;29(6):726\u201332.","journal-title":"J Clin Oncol"},{"issue":"22","key":"3091_CR130","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1200\/JCO.2006.06.0855","volume":"24","author":"JA Meyerhardt","year":"2006","unstructured":"Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006;24(22):3527\u201334.","journal-title":"J Clin Oncol"},{"issue":"22","key":"3091_CR131","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1001\/archinternmed.2009.412","volume":"169","author":"JA Meyerhardt","year":"2009","unstructured":"Meyerhardt JA, Giovannucci EL, Ogino S, Kirkner GJ, Chan AT, Willett W, et al. Physical activity and male colorectal cancer survival. Arch Intern Med. 2009;169(22):2102\u20138.","journal-title":"Arch Intern Med"},{"issue":"6","key":"3091_CR132","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s00345-016-1914-3","volume":"35","author":"SF Peisch","year":"2017","unstructured":"Peisch SF, Van Blarigan EL, Chan JM, Stampfer MJ, Kenfield SA. Prostate cancer progression and mortality: a review of diet and lifestyle factors. World J Urol. 2017;35(6):867\u201374.","journal-title":"World J Urol"},{"issue":"11","key":"3091_CR133","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1158\/0008-5472.CAN-10-3932","volume":"71","author":"EL Richman","year":"2011","unstructured":"Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research Endeavor. Cancer Res. 2011;71(11):3889\u201395.","journal-title":"Cancer Res"},{"issue":"10","key":"3091_CR134","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1158\/1940-6207.CAPR-15-0132","volume":"8","author":"EL Blarigan Van","year":"2015","unstructured":"Van Blarigan EL, Gerstenberger JP, Kenfield SA, Giovannucci EL, Stampfer MJ, Jones LW, et al. Physical activity and prostate tumor vessel morphology: data from the Health Professionals Follow-up Study. Cancer Prev Res. 2015;8(10):962\u20137.","journal-title":"Cancer Prev Res"},{"key":"3091_CR135","doi-asserted-by":"publisher","unstructured":"Galv\u00e3o DA, Hayne D, Frydenberg M, Chambers SK, Taaffe DR, Spry N, et al. Can exercise delay transition to active therapy in men with low-grade prostate cancer? A multicentre randomised controlled trial. BMJ Open. 2018;8(4). https:\/\/doi.org\/10.1136\/bmjopen-2018-022331 .","DOI":"10.1136\/bmjopen-2018-022331"},{"issue":"4","key":"3091_CR136","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/modpathol.2012.214","volume":"26","author":"S Ogino","year":"2013","unstructured":"Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, et al. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol. 2013;26(4):465\u201384.","journal-title":"Mod Pathol"},{"issue":"2","key":"3091_CR137","doi-asserted-by":"publisher","first-page":"e12617","DOI":"10.1111\/ecc.12617","volume":"27","author":"E Bruno","year":"2018","unstructured":"Bruno E, Roveda E, Vitale J, Montaruli A, Berrino F, Villarini A, et al. Effect of aerobic exercise intervention on markers of insulin resistance in breast cancer women. Eur J Cancer Care. 2018;27(2):e12617.","journal-title":"Eur J Cancer Care"},{"issue":"8","key":"3091_CR138","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/cncr.27466","volume":"118","author":"W Demark-Wahnefried","year":"2012","unstructured":"Demark-Wahnefried W, Campbell KL, Hayes SC. Weight management and its role in breast cancer rehabilitation. Cancer. 2012;118(8):2277\u201387.","journal-title":"Cancer"},{"issue":"6","key":"3091_CR139","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s10585-014-9660-7","volume":"31","author":"K Egan","year":"2014","unstructured":"Egan K, Cooke N, Kenny D. Living in shear: platelets protect cancer cells from shear induced damage. Clin Exp Metastasis. 2014;31(6):697\u2013704.","journal-title":"Clin Exp Metastasis"},{"issue":"4","key":"3091_CR140","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s13058-014-0413-y","volume":"16","author":"SN Garland","year":"2014","unstructured":"Garland SN, Johnson B, Palmer C, Speck RM, Donelson M, Xie SX, et al. Physical activity and telomere length in early stage breast cancer survivors. Breast Cancer Res. 2014;16(4):413.","journal-title":"Breast Cancer Res"},{"key":"3091_CR141","doi-asserted-by":"publisher","first-page":"165078","DOI":"10.1155\/2015\/165078","volume":"2015","author":"S Heber","year":"2015","unstructured":"Heber S, Volf I. Effects of physical (in) activity on platelet function. Biomed Res Int. 2015;2015:165078.","journal-title":"Biomed Res Int"},{"issue":"10","key":"3091_CR142","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1249\/MSS.0b013e31817c92aa","volume":"40","author":"AT Ludlow","year":"2008","unstructured":"Ludlow AT, Zimmerman JB, Witkowski S, Hearn JW, Hatfield BD, Roth SM. Relationship between physical activity level, telomere length, and telomerase activity. Med Sci Sports Exerc. 2008;40(10):1764\u201371.","journal-title":"Med Sci Sports Exerc"},{"issue":"1","key":"3091_CR143","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/MCO.0b013e32834121b1","volume":"14","author":"MA Shammas","year":"2011","unstructured":"Shammas MA. Telomeres, lifestyle, cancer, and aging. Curr Opin Clin Nutr Metab Care. 2011;14(1):28\u201334.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"8","key":"3091_CR144","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1002\/jcp.24539","volume":"229","author":"D Sharma","year":"2014","unstructured":"Sharma D, Brummel-Ziedins KE, Bouchard BA, Holmes CE. Platelets in tumor progression: a host factor that offers multiple potential targets in the treatment of cancer. J Cell Physiol. 2014;229(8):1005\u201315.","journal-title":"J Cell Physiol"},{"key":"3091_CR145","doi-asserted-by":"publisher","first-page":"39975","DOI":"10.1038\/srep39975","volume":"7","author":"S Regmi","year":"2017","unstructured":"Regmi S, Fu A, Luo KQ. High shear stresses under exercise condition destroy circulating tumor cells in a microfluidic system. Sci Rep. 2017;7:39975.","journal-title":"Sci Rep"},{"issue":"7","key":"3091_CR146","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s13238-014-0057-9","volume":"5","author":"J Wang","year":"2014","unstructured":"Wang J, L\u00fc D, Mao D, Long M. Mechanomics: an emerging field between biology and biomechanics. Protein Cell. 2014;5(7):518\u201331.","journal-title":"Protein Cell"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-3091-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-3091-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-3091-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T19:06:56Z","timestamp":1605726416000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-3091-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3091"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-3091-8","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"24 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained through Edith Cowan University\u2019s Human Research Ethics Committee (ID 14266 NEWTON), St John of God Hospital Ethics Committee (ID 969), and Sir Charles Gairdner and Osborne Park Health Group Ethics Committee (ID 2016\u2013118), covering recruiting hospitals sites within the public health system (North Metropolitan Health Service, namely Sir Charles Gairdner Hospital and South Metropolitan Health Service, namely Fiona Stanley Hospital) and private health system (St John of God Hospitals in Subiaco and Murdoch). All patients involved in this study are required to give written informed consent in order to be enrolled for participation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"ADR is a current member of the Research Advisory Committee of the National Breast Cancer Foundation. The remaining authors have no competing interests to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"695"}}